Additionally, a prior study found that SLE patients had higher levels of CD31+/annexin V+/CD42b- EVs compared to healthy individuals, and there was a correlation between these EVs and the median overall BILAG-2004 score following treatment (Parker et al., 2014). This evidence concerns the gene ANXA5 and systemic lupus erythematosus.